Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510)

Montenegro S; Susana Montenegro; Helwig C; Christoph Helwig; Juan-Enrique Schwarze; Schwarze JE; Claire Castello-Bridoux; Castello-Bridoux C; Marque S; Sebastien Marque; Lispi M; Monica Lispi; Thomas D'Hooghe; D'Hooghe T

doi:10.1016/j.jogoh.2023.102640

Letter to the editor in response to 'A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose' by P. Barrière, S. Hamamah, E. Arbo, C. Avril, B. Salle, J.-L. Pouly, et al. (J Gynecol Obstet Hum Reprod. 2023;52(1):102510)

Montenegro S, Susana Montenegro, Helwig C, Christoph Helwig, Juan-Enrique Schwarze, Schwarze JE, Claire Castello-Bridoux, Castello-Bridoux C, Marque S, Sebastien Marque, Lispi M, Monica Lispi, Thomas D'Hooghe, D'Hooghe T

Journal of gynecology obstetrics and human reproduction · 2023 · vol. 52(8) , pp. 102640 · doi:10.1016/j.jogoh.2023.102640 · PMID:37549879

Other OA: green CC-BY-4.0

🔓 Open OA copy View on PubMed View at publisher

⚙ AI-generated summary by qwen3.7-flash, 2026-08-22 ⓘ

This letter to the editor responds to a real-world study comparing a biosimilar recombinant follicle-stimulating hormone against the originator product based on starting dose.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals Biosimilar Pharmaceuticals

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc: last seen: 2026-10-11T09:27:45.537177+00:00
pubmed: last seen: 2026-10-14T06:07:46.192524+00:00
unpaywall: last seen: 2026-08-14T06:25:32.811723+00:00

License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine